Скачать или смотреть HuMOLYTE Study Submitted for Peer Review

The full study can be found here:
https://www.humolyte.com/blog/humolyte-wit...

What if one of the most promising ways to reduce chemotherapy side effects wasn’t developed in a lab — but discovered in nature’s first food?

In this video, we explore groundbreaking early research on a special component found in human milk called 2’-fucosyllactose (2-FL), a human milk oligosaccharide (HMO). Scientists studied whether combining this powerful prebiotic with electrolytes could help protect against one of chemotherapy’s most painful complications: mucositis.

Mucositis can cause severe inflammation and sores throughout the digestive tract — from the mouth to the gut. It can lead to malnutrition, dehydration, electrolyte loss, and in some cases, delays or reductions in life-saving chemotherapy treatment.

In this preclinical animal study, researchers tested a medical food containing 2-FL and electrolytes before administering chemotherapy. The results were remarkable:

Significant reduction in weight loss

Preservation of gut structure under the microscope

Protection observed in both intestinal and oral tissue

Consistent findings across multiple chemotherapy drugs

While this research is still early and conducted in animal models, it opens the door to a potentially powerful new strategy to reduce the burden of chemotherapy side effects and improve quality of life for patients.

Could a compound designed to nourish newborns help protect adults undergoing cancer treatment?

Watch to learn the science behind this fascinating discovery — and what it could mean for the future of supportive cancer care.

If you found this video helpful, consider subscribing for more evidence-based discussions on cancer treatment and supportive care innovations.